Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 2, 2000, Pages 165-169

  Menon, Usha ^a   Talaat, Ahmed ^a   Rosenthal, Adam N ^a   Macdonald, Nicola D ^a   Jeyerajah, Arjun R ^a   Skates, Steven J ^b   Sibley, Karen ^a   David, H ^a   Jacobs, Ian J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; EPITHELIUM; FEMALE; HUMAN; MORPHOLOGY; OVARY; OVARY CANCER; OVARY CYST; PATIENT REFERRAL; PELVIS; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE;

AGED; CA-125 ANTIGEN; CARCINOMA IN SITU; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; POSTMENOPAUSE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0033983672     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11685.x     Document Type: Article

References (14)

1. Campbell S, Bhan V, Royston P, Whitehead MI, Collins WP. Transabdominal ultrasound screening for early ovarian cancer. BMJ 1989; 299: 1363–1367.
2. Bourne TH, Campbell S, Reynolds KM et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ 1993; 306: 1025–1029.
3. Van Nagell JR Jr, Gallion HH, Pavlik EJ, De Priest PD. Ovarian cancer screening. Ovarian cancer screening 1995; 76 (Suppl): 2086–2091.
4. Kurjak A, Shalan H, Kupesic S et al. An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography. J Ultrasound Med 1994; 13: 295–301.
5. Jacobs I, Stabile I, Bridges J et al. Multimodal approach to screening for ovarian cancer. Lancet 1988; 1: 268–271.
6. Jacobs I, Davies AP, Bridges J et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ 1993; 306: 1030–1034.
7. Adonakis GL, Paraskevaidis E, Tsiga S, Seferiadis K, Lolis DE. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol 1996; 65: 221–225.
8. Rosenthal A, Jacobs I. Ovarian cancer screening. Semin Oncol 1998; 25: 315–325.
9. Jacobs IJ, Skates SJ, MacDonald N et al. A pilot randomised control trial of ovarian cancer screening. Lancet 1999; 353: 1207–1210.
10. Menon U, Talaat A, Jeyerajah AR et al. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. Br J Cancer 1999; 80: 1644–1647.
11. Campbell S, Goessens L, Goswamy R, Whitehead M. Real-time ultrasonography for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer Lancet 1982; 1: 425–426.
12. MacDonald N, Sibley K, Rosenthal A et al. A comparison of National Cancer Registry and direct follow-up in the ascertainment of ovarian cancer. Br J Cancer 1999; 80: 1826–1827.
13. Bailey CL, Ueland FR, Land GL et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998; 69: 3–7.
14. Skates SJ, Xu FJ, Yu YH et al. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumour markers. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumour markers 1995; 76 (Suppl): 2004–2010.